{"query":"AltheaDx David Macdonald CEO precision medicine news","follow_up_questions":null,"answer":null,"images":[],"results":[{"url":"https://www.medicalcatalyst.com/projects","title":"Team - Medical Catalyst LLC","content":"Mr. Macdonald has served in CEO and COO roles for over 25 years, most recently as the CEO at First Light Diagnostics, and formerly as a Division President, COO and Vice President at Quest Diagnostics. Mr. Macdonald is a result-oriented, decisive leader with biotech industry expertise in wide variety of medical diagnostic systems, molecular diagnostics, personalized medicine, pharma collaboration, medical devices, research products, and laboratory services. Mr. Macdonald has been an invited speaker at a variety of industry events and has served on several industry Advisory Boards and Boards of Directors. •    Medical Catalyst, LLC, CEO and Lead Catalyst. •    AMLo Biosciences Ltd., Non-Exec Member of the Board of Directors. •    Veramarx, Member of the Board of Directors. •    CEO and Board Member, First Light Diagnostics. •    CEO and Board Member, Agendia. •    CEO and Board Member, AltheaDx. •    CEO and Board Member, Nanomix. •    CEO and Board Member, Progeny Systems. •    Siemens Healthcare Diagnostics Strategic Advisory Board Member. •    California Med Tech Advisory Board Member. •    AdvaMed Emerging Growth Company Council Board of Directors.","score":0.99611557,"raw_content":null},{"url":"https://www.prnewswire.com/news-releases/agendia-hires-david-macdonald-as-chief-operating-officer-mark-willig-as-executive-vp-of-north-american-sales-and-doug-bradley-as-vice-president-of-global-marketing-117730303.html","title":"Agendia Hires David Macdonald as Chief Operating Officer, Mark ...","content":"Macdonald has 25 years of experience commercializing clinical diagnostic systems and laboratory services for companies such as Nova Biomedical,","score":0.9953181,"raw_content":null},{"url":"https://smtp.salesandmarketingnetwork.com/news_key_bs.html?search=1&key=Cancer+Diagnostics","title":"Cancer Diagnostics - Healthcare Sales & Marketing Network News","content":"Agendia Hires David Macdonald as Chief Operating Officer, Mark Willig as Executive VP of North American Sales, and Doug Bradley as Vice President of Global","score":0.8233284,"raw_content":null},{"url":"https://www.medicalcatalyst.com/clients","title":"Testimonials | medical-catalyst","content":"- worked with David at Agendia, AltheaDx, Nanomix and Quest Diagnostics. George Pounds, Nichols Management Group - worked with David as Senior Director Lab Operations at Agendia. “I worked for David at Nanomix. I worked for David at both Nanogen and Nanomix. After all the hard work, David was always ready to reward the team and have a good time.”. David was a pleasure to work with and for, had loads of energy and vision, and supported his team in strong ways. “I have seen quite a few different styles of CEOs. David is one of those that can manage a company with style, a smile on his face, and can bring into the company a great working team spirit and therefore achieve goals before schedule. - worked with David at Nanogen. I found David to be an effective leader by setting forth clear goals and letting his team do the work without micro-managing. It was a great pleasure to work alongside David.”.","score":0.80069196,"raw_content":null},{"url":"http://www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/PMC-Dec-2016-Board-Book-reduced.pdf","title":"[PDF] BOARD OF DIRECTORS MEETING","content":"7, FALL 2016 Developments in Brief 2016 MARCH 8 Centers for Medicare and Medicaid Services Proposes to Test New Model for Paying for Personalized Medicines Reimbursed Under Medicare Part B PAGE 18 MAY 20 MatchMiner Wins Harvard Business School Kraft Precision Medicine Accelerator’s Precision Trials Challenge PAGE 12 JULY 6 Obama Administration Advances Precision Medicine Initiative With Research Funding and Draft Guidance on Next-Generation Sequencing PAGE 06 PERSONALIZED MEDICINE IN BRIEF JULY 15 FDA Releases Draft Guidance on Codevelopment of Drugs and Diagnostics PAGE 18 AUGUST 5 Immunotherapy Trial Results Billed as Win for Personalized Medicine PAGE 08 AUGUST 10 PMC’s Health Care Working Group Identifies 39 Strategies for Integrating Personalized Medicine into Health Care PAGE 10 AUGUST 19 The Institute for Clinical and Economic Review Releases Draft Evidence Report on Non-Small Cell Lung Cancer PAGE 04 Click here to download.","score":0.0073173977,"raw_content":null}],"response_time":0.76,"request_id":"dbc6fb30-85c1-4dbb-af46-31f950c45f7a"}